TrialHeart and vessels2020

Empagliflozin attenuates neointimal hyperplasia after drug-eluting-stent implantation in patients with type 2 diabetes.

Takehiro Hashikata et al.PubMed ↗Publisher ↗

No numbers read from the abstract.